Angelica Loskog
Scientific adviser at NXT2B
About
Angelica is CEO of Lokon Pharma AB and a Professor of Immunotherapy at Uppsala University, working in immune, gene and cell therapy with a focus on cancer and autoimmune disease.
Scientific adviser at NXT2B
Angelica is CEO of Lokon Pharma AB and a Professor of Immunotherapy at Uppsala University, working in immune, gene and cell therapy with a focus on cancer and autoimmune disease.